Federica Re
About
Federica Re is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology.
According to data from OpenAlex, Federica Re has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Federica Re's work include Cardiomyopathy and Myosin Studies (28 papers), Cardiovascular Effects of Exercise (24 papers) and Cardiovascular Function and Risk Factors (15 papers). Federica Re is often cited by papers focused on Cardiomyopathy and Myosin Studies (28 papers), Cardiovascular Effects of Exercise (24 papers) and Cardiovascular Function and Risk Factors (15 papers). Federica Re collaborates with scholars based in Italy, United Kingdom and United States. Federica Re's co-authors include Elisabetta Zachara, Iacopo Olivotto, Francesca Torricelli, Francesca Girolami, Franco Cecchi, Stefano Nistri, Corrado Poggesi, Corinna Armentano, Rachael A. Vaubel and Jeanne L. Theis and has published in prestigious journals such as Circulation, Blood and PLoS ONE.
In The Last Decade
Federica Re
39 papers receiving 1.1k citations
Peers
Federica Re
Elisabetta Zachara Italy
Shaughan Dickie United Kingdom
Aristides Anastasakis Greece
Virginia B. Hebl United States
Josef Veselka Czechia
Makoto Okawa Japan
Federica Ramani Italy
Juan Jiménez‐Jáimez Spain
Andreas Seraphim United Kingdom
Citations per year, relative to Federica Re Federica Re (= 1×)
peers
Elisabetta Zachara
Countries citing papers authored by Federica Re
Since
Specialization
Citations
This map shows the geographic impact of Federica Re's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Re with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Re more than expected).
Fields of papers citing papers by Federica Re
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Federica Re. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Re. The network helps show where Federica Re may publish in the future.
Co-authorship network of co-authors of Federica Re
This figure shows the co-authorship network connecting the top 25 collaborators of Federica Re. A scholar is included among the top collaborators of Federica Re based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Re. Federica Re is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Rossi, Salvatore, Tommaso Nicoletti, Ludovico Luca Sicignano, et al.. (2025). Prevalence and Clinical Correlates of Cerebrovascular Alterations in Fabry Disease: A Cross-Sectional Study. Brain Sciences. 15(2). 166–166.
2.
Re, Federica, Guido Giacalone, Marco Di Francesco, et al.. (2025). Cardiopulmonary exercise test and stress echocardiography in Fabry cardiomyopathy: insights into functional impairment and risk stratification. European Heart Journal - Quality of Care and Clinical Outcomes.
3.
Gabrielli, Domenico, Grazia Canciello, Felice Borrelli, et al.. (2024). Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical setting. Frontiers in Cardiovascular Medicine. 11. 1416600–1416600.
4.
Hálasz, Géza, Francesco Moroni, Guido Giacalone, et al.. (2024). The impact of disopyramide on exercise capacity among patients with obstructive hypertrophic cardiomyopathy: beyond left ventricular outflow tract gradient. European Journal of Preventive Cardiology. 32(12). 1122–1124.
5.
Pontara, Elena, Cristina Vicenzetto, Anna Baritussio, et al.. (2024). Prevalence and Correlates of Anti-DSG2 Antibodies in Arrhythmogenic Right Ventricular Cardiomyopathy and Myocarditis: Immunological Insights from a Multicenter Study. Journal of Clinical Medicine. 13(22). 6736–6736.
6.
Re, Federica, Jesús Peteiro, Milorad Tešić, et al.. (2022). Pulmonary congestion during Exercise stress Echocardiography in Hypertrophic Cardiomyopathy. The International Journal of Cardiovascular Imaging. 38(12). 2593–2604.
7.
Re, Federica, Géza Hálasz, Francesco Moroni, et al.. (2022). Exercise-induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test—echocardiographic study. The International Journal of Cardiovascular Imaging. 38(11). 2345–2352.
8.
Magrì, Damiano, Vittoria Mastromarino, Giovanna Gallo, et al.. (2020). Risk Stratification in Hypertrophic Cardiomyopathy. Insights from Genetic Analysis and Cardiopulmonary Exercise Testing. Journal of Clinical Medicine. 9(6). 1636–1636.
9.
Todiere, Giancarlo, Cinzia Nugara, Giovanni Gentile, et al.. (2019). Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score. The American Journal of Cardiology. 124(8). 1286–1292.
10.
Magrì, Damiano, Piergiuseppe Agostoni, Gianfranco Sinagra, et al.. (2018). Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy. International Journal of Cardiology. 271. 125–131.
11.
Gerbino, Andrea, Irene Bottillo, Serena Milano, et al.. (2017). Functional Characterization of a Novel Truncating Mutation in Lamin A/C Gene in a Family with a Severe Cardiomyopathy with Conduction Defects. Cellular Physiology and Biochemistry. 44(4). 1559–1577.
12.
Bottillo, Irene, Viviana Caputo, Alessandro Paiardini, et al.. (2016). Prediction and visualization data for the interpretation of sarcomeric and non-sarcomeric DNA variants found in patients with hypertrophic cardiomyopathy. Data in Brief. 7. 607–613.
13.
Piras, Paolo, Concetta Torromeo, Federica Re, et al.. (2016). Left Atrial trajectory impairment in Hypertrophic Cardiomyopathy disclosed by Geometric Morphometrics and Parallel Transport. Scientific Reports. 6(1). 34906–34906.
14.
Todiere, Giancarlo, Andrea Barison, Annamaria Del Franco, et al.. (2014). Abnormal T2-STIR Magnetic Resonance in Hypertrophic Cardiomyopathy: A Marker of Advanced Disease and Electrical Myocardial Instability. PLoS ONE. 9(10). e111366–e111366.
15.
Re, Federica, Elisabetta Zachara, Andrea Avella, et al.. (2012). Rest and latent obstruction in hypertrophic cardiomyopathy. Journal of Cardiovascular Medicine. 14(5). 372–379.
16.
Caforio, Alida L.P., Elisabetta Zachara, Federica Re, et al.. (2011). Abstract 13404: Serum Anti-Intercalated Disk Autoantibodies in Arrhythmogenic Right Ventricular Cardiomyopathy are Autoimmune Markers Associated with Pathogenic Desmosomal Mutations. Circulation. 124.
17.
Zachara, Elisabetta, Federica Re, Pasquale Baratta, et al.. (2008). Serum Organ-Specific Anti-Heart Autoantibodies in Arrhythmogenic Right Ventricular Cardiomyopathy Patients and Relatives: Evidence for Autoimmune Involvement in a Genetically-Determined Myocarditis. UCL Discovery (University College London).
18.
Bauer, Timm, Oliver Koeth, Claus Jünger, et al.. (2007). Early percutaneous coronary intervention after fibrinolysis for acute ST elevation myocardial infarction: results of two German multi‐centre registries (ACOS and GOAL). Acute Cardiac Care. 9(2). 97–103.
19.
Girolami, Francesca, Iacopo Olivotto, Ilaria Passerini, et al.. (2006). A molecular screening strategy based on β-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy. Journal of Cardiovascular Medicine. 7(8). 601–607.
20.
Coletta, Claudio, et al.. (1997). Prognostic value of left ventricular volume response during dobutamine stress echocardiography. European Heart Journal. 18(10). 1599–1605.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Elisabetta Zachara Breakdown of academic impact, for papers by Shaughan Dickie Breakdown of academic impact, for papers by Aristides Anastasakis Breakdown of academic impact, for papers by Virginia B. Hebl Breakdown of academic impact, for papers by Josef Veselka Breakdown of academic impact, for papers by Makoto Okawa Breakdown of academic impact, for papers by Federica Ramani Breakdown of academic impact, for papers by Juan Jiménez‐Jáimez Breakdown of academic impact, for papers by Andreas Seraphim